Global Hematology Diagnostics

Global Hematology Diagnostics Market Research Report: Forecast (2021-2026)

By Product Type (Hematology Instruments, Hematology Analyzers, Fully-Automated Hematology Analyzers, Semi-Automated Hematology Analyzers, Flow Cytometers, Others), By End User (Hospitals and Clinics, Read more

  • Healthcare
  • Jul 2021
  • 238
  • HC22005

Hematology is the branch of medicine concerned with the diagnosis, treatment, and study of the nature of the blood and bone marrow. Hematology Diagnostics help identify leukemia, anemia, hemophilia, infection, and blood-clotting disorders.

According to MarkNtel Advisors’ research report, “Global Hematology Diagnostics Market Analysis, 2021,” the market is likely to grow at a CAGR of around 6.9% during 2021-26. The prime factors contributing to the growth of hematology diagnostics across the globe are the technological advancements for new automated analyzers & testers and rising blood-related disorders across both children & elders. Moreover, the rising geriatric population & the number of blood disorder-related incidents are other crucial aspects likely to surge the overall market growth of hematology diagnostics across the globe.

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
CAGR 6.9%
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain, Russia
Asia-Pacific: China, India, Japan, South Korea, Australia
South America: Brazil, and Argentina
Middle East & Africa: UAE, Saudi Arabia, South Africa
Key Companies Profiled Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd.
Unit Denominations USD Million/Billion

 

Impact of COVID-19

The sudden outbreak of the COVID-19 pandemic has impacted most industries due to nationwide lockdown and other stringent restrictions. Initially, the Hematology Diagnostics Market faced challenges due to supply chain disruptions, movement restrictions, and varying demand for different products. However, the widespread pandemic has also pushed the Hematology Diagnostics Market into action by generating new opportunities to develop rapid COVID-19 testing kits. Hence, this aspect is very likely to propel the overall market growth in the forecast period.

Global Hematology Diagnostics Market Research Report: Forecast (2021-2026)

Market Segmentation

Hematology Analyzer Accounted for the Largest Market Share

Based on the Product, the market bifurcates into Hematology Instruments, Hematology Analyzers, Fully-Automated Hematology Analyzers, Semi-Automated Hematology Analyzers, and Flow Cytometers. Of them all, Hematology Analyzers acquired the largest share in the Global Hematology Diagnostics Market in the previous few years. It attributes to the mounting automation and technological advancements in the field. In addition to this, rising demand for advanced instruments that can offer better reliability, sensitivity, safety, and ease of operation further propels the demand for Hematology Analyzers, cites MarkNtel Advisors’ in their research report “Global Hematology Diagnostics Market Analysis, 2021”.  

Reagents Dominated the Market 

Based on the Consumables, the market classifies them into Reagents, Stains, Controls, and Calibrations. Among these segments, Reagents dominated the Global Hematology Diagnostics Market with a significant share in the previous few years. It mainly owes to the increasing diagnosis of blood disorders and other types of infections. Besides, rising awareness regarding the diagnosis process and early detection has led to aid the number of tests, thereby propelling the segment growth.

Regional Landscape

North America Leads the Market with the Highest Share 

Geographically, North America has been leading the Global Hematology Diagnostics Market with the highest share for the past few years, primarily due to the abundant presence of diagnostic centers. In addition to this, an increase in the investments to enhance research and development activities and burgeoning adoption of technologically advanced diagnostics are other essential aspects driving the Global Hematology Diagnostics Market in North America.

Market Drivers

Rising Incidences of Blood-Related Diseases to Boost the Market

The surging blood-related disorders like anemia, blood cancer, hemophilia, and blood clots among children and elders are the prime factors likely to fuel the Global Hematology Diagnostics Market. Additionally, the growing world population suffering from different Hemoglobinopathies is another crucial aspect that shall boost the overall market growth globally in the forecast period.

Market Challenges

Unfavorable Reimbursement Policies

The prime factors restraining the market growth are inadequate healthcare insurance coverage and the high cost of diagnostic procedures. In addition to this, the lack of awareness regarding the diagnostic processes and stringent reimbursement policies are other critical aspects that could hinder the overall market growth during the forecast period.

Competitive Landscape

According to MarkNtel Advisors, the major leading players in the global Hematology Diagnostics market are Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd., etc.

Key Questions Answered in the Market Research Report:

  1. What are the overall market statistics or estimates (Market Overview, Market Size- by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global Hematology Diagnostics Market?
  2. What are the region-wise industry size, growth drivers, and challenges?
  3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Hematology Diagnostics Market? 
  4. Who are the key competitors, their key strengths & weaknesses, and how they perform in the Global Hematology Diagnostics Market based on a competitive benchmarking matrix?
  5. What are the key results derived from the market surveys conducted during the Global Hematology Diagnostics Market study?    

Market Outlook, Segmentation, and Statistics 

  • Impact of COVID-19 on Global Hematology Diagnostics Market
  • Market Size & Analysis
    • By Value
    • By Volume
  • Market Share & Analysis
    • By Product Type
      • Hematology Instruments
      • Hematology Analyzer
      • Fully-automated hematology analyzer
      • Semi-automated hematology analyzer
      • Flow cytometers
      • Others
    • By End-User
      • Hospitals and Clinics
      • Diagnostics Laboratories
      • Academic Institute
      • Commercial Service Providers
      • Others
    • By Consumables
      • Reagents
      • Stains
      • Controls and Calibrations
      • Others
    • By Region
      • North America
      • South America
      • Europe
      • Middle East & Africa
      • Asia-Pacific
    • By Competitors
      • Competition Characteristics
      • Market Share & Analysis
      • Competitive Metrix
  • Global Hematology Diagnostics Market Hotspots & Opportunities
  • Global Hematology Diagnostics Market Regulations & Policy
  • Key Strategic Imperatives for Success and Growth
  • Global Competition Outlook
    • Competition Matrix
    • Company Profile

Frequently Asked Questions

A. The Global Hematology Diagnostics Market is forecast to grow at a CAGR of 6.9% during 2021-26.

A. Abbott Laboratories, Mindray Medical International, Siemens Healthneers, BioSystems, BioRad Laboratories, Horiba, Sysmex Corporation, Nihon Kohden Corporation, Danaher Corporation, F. Hoffman-La-Roche Ltd. are a few of the leading players in the Global Hematology Diagnostics Market.

A. The Hematology Analyzer segment is likely to attain the highest CAGR during the forecast period and maintain its significant market share.

A. North America continues to grow at the highest CAGR during 2021-26, thereby presenting immense opportunities to market players of the Global Hematology Diagnostics Market.

A. Rising development of condition-specific treatment, booming awareness regarding personalized medicines, increase in the number of blood donations, rising prevalence of blood disorders, and technological advancements in hematology are the prime factors fueling the market growth.

A. The widespread pandemic has also pushed the Hematology Diagnostics market into action by generating new opportunities to develop rapid COVID-19 testing kits, thereby propelling the market growth in the forecast period.

1.     Introduction

1.1. Product Definition

1.2. Research Process

1.3. Assumptions

1.4. Market Segmentation

2.     Executive Summary

3.     Expert Verbatim- What our Experts Say?

4.     Global Hematology Diagnostics Market Analysis, 2015-2025F

4.1.   Market Size & Analysis

4.1.1. Market Revenue

4.2.   Market Share & Analysis

4.2.1. By Product Type

4.2.1.1. Hematology Instruments

4.2.1.2. Hematology Analyzer

4.2.1.3. Fully-automated hematology analyzer

4.2.1.4. Semi-automated hematology analyzer

4.2.1.5. Flow cytometers

4.2.1.6. Others

4.2.2. By End User

4.2.2.1. Hospitals and Clinics

4.2.2.2. Diagnostic Laboratories

4.2.2.3. Academic Institute

4.2.2.4. Commercial Service Providers

4.2.2.5. Others

4.2.3. By Consumables

4.2.3.1. Reagents

4.2.3.2. Stains

4.2.3.3. Controls and Calibrations

4.2.3.4. Others

4.2.4. By Region

4.2.4.1. North America

4.2.4.2. South America

4.2.4.3. Europe

4.2.4.4. Middle East & Africa

4.2.4.5. Asia-Pacific

4.2.5. By Company

4.2.5.1. Revenue Shares

4.2.5.2. Strategic Factorial Indexing

4.2.5.3. Competitor Placement in MarkNtel Quadrant

5.     North America Hematology Diagnostics Market Analysis, 2015-2025F

5.1.   Market Size & Analysis

5.1.1. Market Revenue

5.2.   Market Share & Analysis

5.2.1. By Product Type

5.2.2. By End User

5.2.3. By Consumables

5.2.4. By Country

5.2.4.1. United States

5.2.4.2. Canada

5.2.4.3. Mexico

5.3.   United States Hematology Diagnostics Market Analysis, 2015-2025F

5.3.1. Market Size & Analysis

5.3.1.1. Market Revenue

5.3.2. Market Share & Analysis

5.3.2.1. By Product Type

5.3.2.2. By End User

5.3.2.3. By Consumables

5.4.   Canada Hematology Diagnostics Market Analysis, 2015-2025F

5.4.1. Market Size & Analysis

5.4.1.1. Market Revenue

5.4.2. Market Share & Analysis

5.4.2.1. By Product Type

5.4.2.2. By End User

5.4.2.3. By Consumables

5.5.   Mexico Hematology Diagnostics Market Analysis, 2015-2025F

5.5.1. Market Size & Analysis

5.5.1.1. Market Revenue

5.5.2. Market Share & Analysis

5.5.2.1. By Product Type

5.5.2.2. By End User

5.5.2.3. By Consumables

6.     South America Hematology Diagnostics Market Analysis, 2015-2025F

6.1.   Market Size & Analysis

6.1.1. Market Revenue

6.2.   Market Share & Analysis

6.2.1. By Product Type

6.2.2. By End User

6.2.3. By Consumables

6.2.4. By Country

6.2.4.1. Brazil

6.2.4.2. Argentina

6.3.   Brazil Hematology Diagnostics Market Analysis, 2015-2025F

6.3.1. Market Size & Analysis

6.3.1.1. Market Revenue

6.3.2. Market Share & Analysis

6.3.2.1. By Product Type

6.3.2.2. By End User

6.3.2.3. By Consumables

6.4.   Argentina Hematology Diagnostics Market Analysis, 2015-2025F

6.4.1. Market Size & Analysis

6.4.1.1. Market Revenue

6.4.2. Market Share & Analysis

6.4.2.1. By Product Type

6.4.2.2. By End User

6.4.2.3. By Consumables

7.     Europe Hematology Diagnostics Market Analysis, 2015-2025F

7.1.   Market Size & Analysis

7.1.1. Market Revenue

7.2.   Market Share & Analysis

7.2.1. By Product Type

7.2.2. By End User

7.2.3. By Consumables

7.2.4. By Country

7.2.4.1. France

7.2.4.2. Germany

7.2.4.3. Italy

7.2.4.4. United Kingdom

7.2.4.5. Spain

7.3.   France Hematology Diagnostics Market Analysis, 2015-2025F

7.3.1. Market Size & Analysis

7.3.1.1. Market Revenue

7.3.2. Market Share & Analysis

7.3.2.1. By Product Type

7.3.2.2. By End User

7.3.2.3. By Consumables

7.4.   Germany Hematology Diagnostics Market Analysis, 2015-2025F

7.4.1. Market Size & Analysis

7.4.1.1. Market Revenue

7.4.1.2. Units Sold

7.4.2. Market Share & Analysis

7.4.2.1. By Product Type

7.4.2.2. By End User

7.4.2.3. By Consumables

7.5.   Italy Hematology Diagnostics Market Analysis, 2015-2025F

7.5.1. Market Size & Analysis

7.5.1.1. Market Revenue

7.5.2. Market Share & Analysis

7.5.2.1. By Product Type

7.5.2.2. By End User

7.5.2.3. By Consumables

7.6.   United Kingdom Hematology Diagnostics Market Analysis, 2015-2025F

7.6.1. Market Size & Analysis

7.6.1.1. Market Revenue

7.6.2. Market Share & Analysis

7.6.2.1. By Product Type

7.6.2.2. By End User

7.6.2.3. By Consumables

7.7.   Spain Hematology Diagnostics Market Analysis, 2015-2025F

7.7.1. Market Size & Analysis

7.7.1.1. Market Revenue

7.7.2. Market Share & Analysis

7.7.2.1. By Product Type

7.7.2.2. By End User

7.7.2.3. By Consumables

8.     Middle East and Africa Hematology Diagnostics Market Analysis, 2015-2025F

8.1.   Market Size & Analysis

8.1.1. Market Revenue

8.2.   Market Share & Analysis

8.2.1. By Product Type

8.2.2. By End User

8.2.3. By Consumables

8.2.4. By Country

8.2.4.1. UAE

8.2.4.2. Saudi Arabia

8.3.   UAE Hematology Diagnostics Market Analysis, 2015-2025F

8.3.1. Market Size & Analysis

8.3.1.1. Market Revenue

8.3.2. Market Share & Analysis

8.3.2.1. By Product Type

8.3.2.2. By End User

8.3.2.3. By Consumables

8.4.   Saudi Arabia Hematology Diagnostics Market Analysis, 2015-2025F

8.4.1. Market Size & Analysis

8.4.1.1. Market Revenue

8.4.2. Market Share & Analysis

8.4.2.1. By Product Type

8.4.2.2. By End User

8.4.2.3. By Consumables

8.5.   South Africa Hematology Diagnostics Market Analysis, 2015-2025F

8.5.1. Market Size & Analysis

8.5.1.1. Market Revenue

8.5.2. Market Share & Analysis

8.5.2.1. By Product Type

8.5.2.2. By End User

8.5.2.3. By Consumables

9.     Asia-Pacific Hematology Diagnostics Market Analysis, 2015-2025F

9.1.   Market Size & Analysis

9.1.1. Market Revenue

9.2.   Market Share & Analysis

9.2.1. By Product Type

9.2.2. By End User

9.2.3. By Consumables

9.2.4. By Country

9.2.4.1.   China

9.2.4.2.   India

9.2.4.3.   Japan

9.2.4.4.   Australia

9.2.4.5.   South Korea

9.3.   China Hematology Diagnostics Market Analysis, 2015-2025F

9.3.1. Market Size & Analysis

9.3.1.1.   Market Revenue

9.3.2. Market Share & Analysis

9.3.2.1.    By Product Type

9.3.2.2.    By End User

9.3.2.3.    By Consumables

9.4.   India Hematology Diagnostics Market Analysis, 2015-2025F

9.4.1. Market Size & Analysis

9.4.1.1.    Market Revenue

9.4.2. Market Share & Analysis

9.4.2.1.     By Product Type

9.4.2.2.     By End User

9.4.2.3.     By Consumables

9.5.   Japan Hematology Diagnostics Market Analysis, 2015-2025F

9.5.1. Market Size & Analysis

9.5.1.1.     Market Revenue

9.5.2. Market Share & Analysis

9.5.2.1.     By Product Type

9.5.2.2.     By End User

9.5.2.3.     By Consumables

9.6.   Australia Hematology Diagnostics Market Analysis, 2015-2025F

9.6.1. Market Size & Analysis

9.6.1.1.   Market Revenue

9.6.2. Market Share & Analysis

9.6.2.1.    By Product Type

9.6.2.2.    By End User

9.6.2.3.    By Consumables

9.7.   South Korea Hematology Diagnostics Market Analysis, 2015-2025F

9.7.1. Market Size & Analysis

9.7.1.1.   Market Revenue

9.7.2. Market Share & Analysis

9.7.2.1.    By Product Type

9.7.2.2.    By End User

9.7.2.3.    By Consumables

10.  Global Hematology Diagnostics Market Policies, Regulations, Product Standards

11.  Global Hematology Diagnostics Market Trends & Insights

12.  Global Hematology Diagnostics Market Dynamics

12.1.Growth Drivers

12.2.Challenges

12.3.Impact Analysis

13.  Global Hematology Diagnostics Market Hotspot & Opportunities

14.  Global Hematology Diagnostics Market Key Strategic Imperatives for Success & Growth

15.  Global Competition Outlook

15.1.  Competition Matrix

15.1.1. Product Portfolio

15.1.2. Brand Specialization

15.1.3. Target Markets

15.1.4. Target End Users

15.1.5. Research & Development

15.1.6. Strategic Alliances

15.1.7. Strategic Initiatives

15.2.  Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)

15.2.1.   Abbott Laboratories

15.2.2.   Mindray Medical International

15.2.3.   Siemens Healthneers

15.2.4.   BioSystems

15.2.5.   BioRad Laboratories

15.2.6.   Horiba

15.2.7.   Symex Corporation

15.2.8.   Nihon Kohden Corpration

15.2.9.   Danaher Corporation

15.2.10.  F. Hoffman-La-Roche Ltd.

16.  Disclaimer

Hematology Diagnostics Market Segmentation